Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
HIV self-testing among female sex workers
United Therapeutics Europe Ltd
Human Immunodeficiency Virus (HIV)
1 trial -
Health education and conservative management of clinical routines
The First People's Hospital of Lianyungang
Recurrent Acute Pancreatitis
1 trial -
HellenCare
The First People's Hospital of Lianyungang
Alzheimer's Disease Dementia
1 trial -
Heparin Sodium
The First People's Hospital of Lianyungang
Cerebral Aneurysm
1 trial -
High Dose Vitamin D
Atrium Therapeutics
Breast
1 trial -
High Fat
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
High Hyaluronic Acid concentrations (0.5 mg/ml)
NORTHWEST BIOTHERAPEUTICS INC
Infertility
1 trial -
High energy high protein peptide feed study
United Therapeutics Europe Ltd
Malnutrition
1 trial -
High risk experimental group
The First People's Hospital of Lianyungang
Adolescent Idiopathic Scoliosis
1 trial -
High-amylose maize starch+acetate/butyrate
United Therapeutics Europe Ltd
Aerobic Endurance
1 trial -
High-dose vitamin D2 softgels
The First People's Hospital of Lianyungang
Chronic Kidney Disease 5D
1 trial -
Huang-long Zhi-xiao Granule
The First People's Hospital of Lianyungang
Asthma Chronic
1 trial -
Huangqi Guizhi Wuwu decoction
The First People's Hospital of Lianyungang
Diabetic Nephropathies
1 trial -
Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Hydroxyurea
United Therapeutics Europe Ltd
Thrombocythemia
1 trial -
Hypofractionated Radiation Therapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Hypofractionated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
IMIQUIMOD cream 50mg/g
BRIGHT MINDS BIOSCIENCES INC.
Cutaneous Lupus Erythematosus
1 trial -
IORT
The First People's Hospital of Lianyungang
Laryngeal Neoplasms
1 trial -
IPT plus HD-tDCS
The First People's Hospital of Lianyungang
Depressive Disorder
1 trial -
Ibuprofen
United Therapeutics Europe Ltd
Immune System and Related Disorders
1 trial -
Immune-enhancing nutritional beverage
United Therapeutics Europe Ltd
Mitigation of Immune Function Decrements in Response to Stress
1 trial -
Immunosuppressive therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
In-stent Restenosis Lesion
1 trial -
Inactivated influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources